Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1158, 2007-01, pp. : 3-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Rosiglitazone and MI risk - will we ever know the answer?
Inpharma, Vol. 1, Iss. 1594, 2007-01 ,pp. :
Access to resources
Recommend
Pioglitazone, rosiglitazone face up to MI, HF risk analyses
Reactions Weekly, Vol. 1, Iss. 1170, 2007-01 ,pp. :
Pioglitazone, rosiglitazone face up to MI, HF risk analyses
Inpharma, Vol. 1, Iss. 1605, 2007-01 ,pp. :
By Wolffenbuttel B.H. Sels J-P. Huijberts M.S.
Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 3, 2001-03 ,pp. :
By Barman Balfour J.A. Plosker G.L.
Drugs, Vol. 57, Iss. 6, 1999-06 ,pp. :